EyeGene Inc. | Cash Flow
Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,854,859.00
2,925,835.00
4,897,091.00
8,269,838.00
8,450,890.00
Depreciation, Depletion & Amortization
38,055.00
76,533.00
108,040.00
171,333.00
421,666.00
Other Funds
-
-
192,815.60
115,783.90
154,958.40
Funds from Operations
3,016,647.30
2,597,942.50
4,427,927.80
5,977,253.40
6,605,195.50
Changes in Working Capital
666,694.10
182,701.60
51,144.00
8,999.00
154,262.00
Net Operating Cash Flow
3,683,341.40
2,415,240.90
4,479,071.80
5,986,252.40
6,759,457.50
Capital Expenditures
69,129.90
398,237.50
129,128.80
1,491,322.60
272,695.40
Purchase/Sale of Investments
4,500,140.00
3,430,549.60
15,316,476.90
2,516,155.80
8,007,496.00
Net Investing Cash Flow
4,570,117.20
3,032,312.20
15,445,605.70
615,953.80
8,280,191.40
Issuance/Reduction of Debt, Net
-
-
-
-
5,400,000.00
Net Financing Cash Flow
5,584,812.00
1,700,946.00
23,211,363.90
288,264.50
18,657,586.10
Net Change in Cash
2,668,646.50
2,318,017.30
3,286,686.50
5,082,034.20
3,617,937.20
Free Cash Flow
3,687,264.30
2,767,316.50
4,579,048.20
7,353,829.90
6,909,460.40
Other Sources
-
-
-
94,242.70
-
Change in Capital Stock
5,584,812.00
1,700,946.00
23,404,179.50
172,480.60
13,102,627.70
Other Uses
847.30
-
-
503,122.20
-
About EyeGene
View Profile
